ã©ã¤ãã£ã³ã°ã®å²å¦ãèªãã§ããããããããããã°ãçºè¦ããã
Â
ã¨ãããåèé ä¹å çã®çºè¨ã
ã¤ã³ã¿ã¼ãããä¸ã®è¨äºãä½ãã ãããªã¨æã£ã¦æ¤ç´¢ãããããããããããã°ãè¦ã¤ããã
ãé£äºæååºæºã«åºã¥ãã¦ãã¨ããã¾ãããé£äºæååºæºã®æ´å²ãè¦ãã°ãå¤ç¯ã®æ´å²ãã®ãã®ã§ãããã¨ããããã¾ããå¿ãã¦ãããªããã¨ã¯ãç§ãã¡ãçãã¦ããããã§å¿ è¦ãªæ é¤ç´ ã®ç¨®é¡ãéãã ããããã£ã¦ããªãã¨ãããã¨ã§ããä»ãããã£ã¦ããç¯å²ã§ã¯ã¨ããåææ¡ä»¶ãå¿ãã¦ã¯ããã¾ãããããã¦ãç§ãã¡ã¯å¸¸ã«å¯å£«å±±ã®ï¼åç®ã«ããã¨ããé¯è¦ã«é¥ããã¡ã ã¨ãããã¨ã§ããï¼ï¼ï¼å¹´çµã£ã¦ã¿ãããå®ã¯ä¸åç®ã«ãçãã¦ããªãã£ãã¨ããå¯è½æ§ãããã¾ãã
ããã§ãããããã¯äºå®ã§ãè ¸å ç´°èå¢ã®ç 究ã ãã§ããé£ã¹ãã¨ã¯ä½ããããããªããªã£ã¦ãã¦ãã¾ãã人éã¯ãã®ãé£ã¹ã¦å解ãã¦ããã ãã§ã¯ãªããé£ã¹ãããè ¸å ç´°èãã¡ã«åãä¸ãã¦ãã¾ããã¤ã¾ãå ±çé¢ä¿ãããã¾ããè ¸å ç´°èã代è¬ããç©è³ªã人éãåãè¾¼ããã¨ããè ¸å ç´°èã®ãããã§å ç«ãæ´èµ°ããã«ãããã¨ãããã£ã¦ãã¾ããæ°å ãªã¼ãã¼ã®ç´°èãã¡ãç¶æãããã¨ãé£äºãªã®ã§ãã©ãã¾ã§ãæ é¤ãã ãªãã¦ç°¡åãªåé¡ã§ã¯ãªãã®ã§ãã
ã¡ããã©å æ¥èªã¿çµããåã¨å èã«ãåæ§ã®ãã¨ãæ¸ããã¦ãã¾ãããã©ãããè ¸å ç´°èã®è¡°ãã¨èªå·±å ç«ç¾æ£ãªã©ã¯é¢ä¿ããããããã
ããããCOVID-19ã¨è ¸å ç´°èå¢ã¯é¢ä¿ãããã®ã ãããï¼ã¨æã£ã¦èª¿ã¹ãããããã仮説ãããããã ã£ãã
COVID-19ã®çç¶ã人ã«ãã£ã¦éãã®ã¯ç´°èå¢ã®éãã§ã¯ãªãããã¨ãããã¨ã ãæ¨ä»ã®å ç«ã®ç解ããããã¨ããããããªè©±ã§ããã
Â
ã¡ãªã¿ã«ãå ã®æ é¤å£«ããã®ããã°ã¯ãããã¨ãããããã¦ã¨ãã»ã¤ã¨ãã¦ã¬ãã«ãé«ãããã¯ãã¤ã³ã¿ã¼ããããæ¨ã¦ããã®ã§ã¯ãªããã¿ãªããSNSã«ããã£ã¦ã¤ã³ã¿ã¼ãããã«çµ¶æãã¦ãã¾ãããã¤ã³ã¿ã¼ãããã¯SNSã ãã§ã¯ãªããå¤ãè¦ã¾ãããã
ãã®ããã°ã¯ãã¡ãã£ã¨é è²ããã¤ãã¦èªã¿ã¥ããã®ã ããããã¯å¤ãè¯ãã¤ã³ã¿ã¼ãããã®ã»ã³ã¹ã¨ãããã¨ã«ãã¦ããã¾ããããéã¨é»è²ã§ã¦ã¯ã©ã¤ãã®å½æã®ããã§ããã